{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T19:32:54Z","timestamp":1785007974105,"version":"3.55.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008386","name":"Marmara \u00dcniversitesi","doi-asserted-by":"publisher","award":["SAG-C-TUP-081117-0613"],"award-info":[{"award-number":["SAG-C-TUP-081117-0613"]}],"id":[{"id":"10.13039\/501100008386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.cyto.2021.155585","type":"journal-article","created":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T20:36:59Z","timestamp":1621802219000},"page":"155585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Serum high-sensitivity C-reactive protein, tumor necrosis factor-\u03b1, interleukin (IL)-1\u03b2, IL-17A and IL-23 levels in patients with hidradenitis suppurativa"],"prefix":"10.1016","volume":"144","author":[{"given":"Gonca","family":"Sara\u00e7 \u00d6zt\u00fcrk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00fclin","family":"Ergun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130rem","family":"Peker Ey\u00fcbo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Akkiprik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2021.155585_b0005","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J. Eur. Acad. Dermatology Venereol."},{"issue":"6","key":"10.1016\/j.cyto.2021.155585_b0010","first-page":"e171","article-title":"Profound consequences of hidradenitis suppurativa: a review","volume":"183","author":"Matusiak","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cyto.2021.155585_b0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jdin.2020.05.005","article-title":"Hidradenitis suppurativa is an autoinflammatory keratinization disease: A review of the clinical, histologic, and molecular evidence","volume":"1","author":"Frew","year":"2020","journal-title":"JAAD Int."},{"key":"10.1016\/j.cyto.2021.155585_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21228436","article-title":"Cytokine pathways and investigational target therapies in hidradenitis suppurativa","volume":"21","author":"Del Duca","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2021.155585_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0031810","article-title":"Increased prevalence of metabolic syndrome in patients with Acne inversa","volume":"7","author":"Sabat","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.cyto.2021.155585_b0030","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1159\/000448838","article-title":"High prevalence of back pain and axial spondyloarthropathy in patients with hidradenitis suppurativa","volume":"232","author":"Schneider-Burrus","year":"2017","journal-title":"Dermatology."},{"key":"10.1016\/j.cyto.2021.155585_b0035","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/jamadermatol.2019.0891","article-title":"Association of Hidradenitis Suppurativa With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis","volume":"155","author":"Chen","year":"2019","journal-title":"JAMA Dermatology."},{"key":"10.1016\/j.cyto.2021.155585_b0040","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jaad.2014.09.012","article-title":"Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: A chart-verified case-control analysis","volume":"71","author":"Shlyankevich","year":"2014","journal-title":"J. Am. Dermatology."},{"key":"10.1016\/j.cyto.2021.155585_b0045","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-020-0149-1","article-title":"Hidradenitis suppurativa","volume":"6","author":"Sabat","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.cyto.2021.155585_b0050","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","article-title":"Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa","volume":"65","author":"Schlapbach","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.cyto.2021.155585_b0055","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/bjd.14075","article-title":"Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa","volume":"173","author":"Kelly","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cyto.2021.155585_b0060","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2340\/00015555-0749","article-title":"Increased serum tumour necrosis factor-\u03b1 in hidradenitis suppurativa patients: Is there a basis for treatment with anti-tumour necrosis factor-\u03b1 agents?","volume":"89","author":"Matusiak","year":"2009","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.cyto.2021.155585_b0065","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2016.10.042","article-title":"Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents","volume":"76","author":"Matusiak","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.cyto.2021.155585_b0070","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/bjd.14338","article-title":"Ustekinumab in hidradenitis suppurativa: Clinical results and a search for potential biomarkers in serum","volume":"174","author":"Blok","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cyto.2021.155585_b0075","doi-asserted-by":"crossref","first-page":"2450401","DOI":"10.1155\/2017\/2450401","article-title":"The Clinical Significance of Increased Serum Proinflammatory Cytokines, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Patients with Hidradenitis Suppurativa","volume":"2017","author":"Jim\u00e9nez-Gallo","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cyto.2021.155585_b0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cyto.2017.12.020","article-title":"Effects of adalimumab on T-helper-17 lymphocyte- and neutrophil-related inflammatory serum markers in patients with moderate-to-severe hidradenitis suppurativa","volume":"103","author":"Jim\u00e9nez-Gallo","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2021.155585_b0085","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jaad.2016.08.036","article-title":"Interleukin 6 and high-sensitivity C-reactive protein are potential predictive markers of response to infliximab in hidradenitis suppurativa","volume":"76","author":"Montaudie","year":"2017","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662100168X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662100168X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:00:08Z","timestamp":1760907608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104346662100168X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":17,"alternative-id":["S104346662100168X"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155585","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum high-sensitivity C-reactive protein, tumor necrosis factor-\u03b1, interleukin (IL)-1\u03b2, IL-17A and IL-23 levels in patients with hidradenitis suppurativa","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155585"}}